Mereo BioPharma Files Q1 2025 10-Q Report
Ticker: MREO · Form: 10-Q · Filed: May 13, 2025 · CIK: 1719714
| Field | Detail |
|---|---|
| Company | Mereo Biopharma Group PLC (MREO) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, biopharma
TL;DR
Mereo BioPharma's Q1 2025 10-Q is in. Check financials.
AI Summary
Mereo BioPharma Group plc filed its 10-Q for the period ending March 31, 2025. The company reported on its financial performance and business operations. Key financial data and operational details are presented in this quarterly report.
Why It Matters
This filing provides investors with an update on Mereo BioPharma's financial health and operational progress for the first quarter of 2025, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a biopharmaceutical company, Mereo BioPharma is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 20250331 — Period End Date (The report covers the financial period ending on this date.)
- 20250513 — Filing Date (The date the report was officially submitted to the SEC.)
Key Players & Entities
- Mereo BioPharma Group plc (company) — Filer of the 10-Q report
- 20250331 (date) — Conformed period of report
- 20250513 (date) — Filed as of date
- 001-38452 (company) — SEC file number
- Setrusumab BPS-804UX143 (company) — Product candidate mentioned
FAQ
What is the reporting period for this 10-Q filing?
The conformed period of report is 20250331, meaning it covers the quarter ending March 31, 2025.
When was this 10-Q filing submitted to the SEC?
The filing was submitted on 20250513.
What is the SEC file number for Mereo BioPharma Group plc?
The SEC file number is 001-38452.
What is the Central Index Key (CIK) for Mereo BioPharma Group plc?
The Central Index Key for Mereo BioPharma Group plc is 0001719714.
Does the filing mention any specific product candidates?
Yes, the filing mentions 'Setrusumab BPS-804UX143' in the context of operating segments.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Mereo BioPharma Group plc (MREO).